Filing Details
- Accession Number:
- 0001209191-19-052541
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-04 16:11:26
- Reporting Period:
- 2019-10-02
- Accepted Time:
- 2019-10-04 16:11:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-02 | 1,270 | $125.71 | 7,810 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-10-02 | 5,818 | $126.68 | 13,628 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-02 | 1,960 | $166.08 | 11,668 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-02 | 5,187 | $166.82 | 6,481 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-02 | 1,232 | $167.88 | 5,249 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2019-10-02 | 1,270 | $0.00 | 1,270 | $125.71 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2019-10-02 | 5,818 | $0.00 | 5,818 | $126.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,907 | 2027-05-31 | No | 4 | M | Direct | |
| 8,729 | 2025-06-03 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $166.08 (range $165.39 to $166.38).
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $166.82 (range $166.40 to $167.35).
- Open market sales reported on this line occurred at a weighted average price of $167.88 (range $167.50 to $168.36).
- Fully vested.
Billionaire Hedge Funds
